What is BrightInsight?
BrightInsight operates a premier global platform specifically engineered for the biopharma and medtech industries. The company specializes in regulated digital health solutions, including Software as a Medical Device (SaMD), advanced data insights, and comprehensive disease management tools. By providing the underlying architecture for companion apps and connected medical products, BrightInsight enables life sciences firms to optimize patient care and improve therapeutic outcomes. The platform is widely recognized for its ability to bridge the gap between complex regulatory requirements and the need for scalable, user-centric digital health experiences, serving as a foundational partner for many of the world's leading pharmaceutical organizations.
How much funding has BrightInsight raised?
BrightInsight has raised a total of $179M across 4 funding rounds:
Series A
$25M
Series B
$40M
Series C
$101M
Unspecified
$13M
Series A (2019): $25M with participation from New Leaf Venture Partners and Eclipse Ventures
Series B (2020): $40M led by Eclipse, New Leaf Venture Partners, and Insight Partners
Series C (2021): $101M supported by Eclipse Ventures Incorporated, General Catalyst Partners, New Leaf Venture Partners, and Insight Partners
Unspecified (2026): $13M featuring New Leaf Venture Partners, General Catalyst, Mayo Clinic, and Insight Partners
Key Investors in BrightInsight
New Leaf Venture Partners
A venture capital firm dedicated to corporate technology spinouts, providing a systematic process for commercializing innovations and bridging the gap between R&D labs and market-ready solutions.
General Catalyst
A prominent venture capital firm that partners with founders to accelerate growth and build enduring enterprises across diverse sectors, including healthcare and enterprise software.
Insight Partners
A global venture capital and private equity firm focused on high-growth software and technology companies, providing both capital and hands-on operational support to scale businesses.
What's next for BrightInsight?
With the successful closure of this latest financing round, BrightInsight is poised to accelerate its product roadmap and deepen its penetration into global healthcare markets. The strategic focus will likely center on enhancing the platform's interoperability and expanding its suite of data-driven insights to meet the evolving needs of its enterprise customer base. As the digital health ecosystem continues to consolidate, BrightInsight's ability to provide a secure, compliant, and scalable environment for connected health products will be a key differentiator. The company is expected to leverage its strong investor network to navigate the complexities of international healthcare regulations while continuing to drive innovation in patient-centric digital therapeutics.
See full BrightInsight company page
